Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Simu K. Thomas
ResearcherPublications, citations & collaboration network
Simu K. Thomas is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 76 works, 1,892 citations, an h-index of 25 and an i10-index of 34.
76
Works
1,892
Citations
25
h-index
34
i10-index
IDs:OpenAlex
How has Simu K. Thomas's publication output changed over time?
ScholarIQpublication output · 1998–2012
Output grew0% over the shown period — from 1 works in 1998 to 1 in 2012.
1
1
2
5
1
1
199820052006200720092012
What are the most-cited papers on Simu K. Thomas?
ScholarIQmost cited works
Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs
Theodore Darkow, Henry J. Henk, Simu K. Thomas, Weiwei Feng, Jean‐François Baladi, George A. Goldberg, Alan K. Hatfield, Jörge E. Cortes
PharmacoEconomics. 2007267 Citations
Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion‐dependent thalassemia: a literature review
Thomas E. Delea, John Edelsberg, Oleg Sofrygin, Simu K. Thomas, Jean‐François Baladi, Pradyumna D. Phatak, Thomas D. Coates
S186746772. 2007180 Citations
Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease
Bengt Winblad, Ariane K. Kawata, Kathleen Beusterien, Simu K. Thomas, Anders Wimo, Roger Lane, Howard Fillit, Rafael Blesa
International Journal of Geriatric Psychiatry. 2007100 Citations
Risk of Cancer Treatment—Associated Bone Loss and Fractures Among Women with Breast Cancer Receiving Aromatase Inhibitors
Betty A. Mincey, Mei Sheng Duh, Simu K. Thomas, Érick Moyneur, Maryna Marynchencko, Simone Peart Boyce, David Mallett, Edith A. Perez
Clinical Breast Cancer. 200692 Citations
Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial
Paul Mitchell, Lieven Annemans, Meghan Gallagher, Rafiq Hasan, Simu K. Thomas, Kerry Gairy, M.S. Knudsen, Henrietta Onwordi
British Journal of Ophthalmology. 201282 CitationsOPEN ACCESS
Related on ScholarIQ
Alexion Pharmaceuticals (United States)
Institution
Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs
Paper
Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion‐dependent thalassemia: a literature review
Paper
Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease
Paper
Risk of Cancer Treatment—Associated Bone Loss and Fractures Among Women with Breast Cancer Receiving Aromatase Inhibitors
Paper
Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial
Paper